Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
for Peripheral Arterial Disease
Drug: Orforglipron
30 locations incl. Birmingham
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07223593·Phase 3·Recruiting
Alabama has 1,359 paid clinical trials enrolling now across cities including Birmingham, Mobile and Huntsville. Search by condition, age, or phase to find compensated research studies accepting participants near you.
Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .